Low-level vancomycin resistance was observed for 28 clinical Clostridium innocuum isolates and C. innocuum NCIB 10674, whereas teicoplanin was active. DNA from three clinical isolates and the type strain could not be amplified by PCR with primers specific for the genes vanA, vanB, and vanC, suggesting that C. innocuum is intrinsically resistant to vancomycin.
CITATION STYLE
Mory, F., Lozniewski, A., David, V., Carlier, J. P., Dubreuil, L., & Leclercq, R. (1998). Low-level vancomycin resistance in Clostridium innocuum. Journal of Clinical Microbiology, 36(6), 1767–1768. https://doi.org/10.1128/jcm.36.6.1767-1768.1998
Mendeley helps you to discover research relevant for your work.